217 related articles for article (PubMed ID: 32483729)
1. Radiopharmaceuticals for Treatment of Osteosarcoma.
Anderson PM
Adv Exp Med Biol; 2020; 1257():45-53. PubMed ID: 32483729
[TBL] [Abstract][Full Text] [Related]
2. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
Anderson PM; Subbiah V; Rohren E
Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
[TBL] [Abstract][Full Text] [Related]
3. 223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy.
Anderson PM; Scott J; Parsai S; Zahler S; Worley S; Shrikanthan S; Subbiah V; Murphy E
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32303572
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Samarium for osteoblastic bone metastases and osteosarcoma.
Anderson P
Expert Opin Pharmacother; 2006 Aug; 7(11):1475-86. PubMed ID: 16859431
[TBL] [Abstract][Full Text] [Related]
6. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
Anderson P; Nuñez R
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
[TBL] [Abstract][Full Text] [Related]
7.
Kairemo K; Roszik J; Anderson P; Ravizzini G; Rao A; Macapinlac HA; Subbiah V
Curr Probl Cancer; 2021 Oct; 45(5):100797. PubMed ID: 34706830
[TBL] [Abstract][Full Text] [Related]
8. Relapsed Osteosarcoma Trial Concepts to Match the Complexity of the Disease.
Reed DR; Hingorani P; Anderson PM
Adv Exp Med Biol; 2020; 1257():85-94. PubMed ID: 32483733
[TBL] [Abstract][Full Text] [Related]
9.
Alves CRR; Faria DP; Carneiro CG; Garcez AT; Gutierrez VP; das Neves W; de Almeida NR; Cury Y; Chammas R; Brum PC
Life Sci; 2018 Aug; 206():29-34. PubMed ID: 29778807
[TBL] [Abstract][Full Text] [Related]
10. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature.
Ong WL; Koh TL; Lim Joon D; Chao M; Farrugia B; Lau E; Khoo V; Lawrentschuk N; Bolton D; Foroudi F
BJU Int; 2019 Nov; 124 Suppl 1():19-30. PubMed ID: 31507035
[TBL] [Abstract][Full Text] [Related]
12. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma.
Anderson PM; Wiseman GA; Erlandson L; Rodriguez V; Trotz B; Dubansky SA; Albritton K
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6895-900. PubMed ID: 16203780
[TBL] [Abstract][Full Text] [Related]
14. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
15. [SPECT/CT radiation in treatment of bone metastases of osteosarcoma].
Ryzhkov AD; Ivanov SM; Shiryaev SV; Krylov AS; Stanyakina EE; Kochergina NV; Bludov AB; Nazarenko AV
Vopr Onkol; 2016; 62(5):654-659. PubMed ID: 30695593
[TBL] [Abstract][Full Text] [Related]
16. Radiopharmaceuticals for Palliation of Bone Pain in Patients with Castration-resistant Prostate Cancer Metastatic to Bone: A Systematic Review.
Jong JM; Oprea-Lager DE; Hooft L; de Klerk JM; Bloemendal HJ; Verheul HM; Hoekstra OS; van den Eertwegh AJ
Eur Urol; 2016 Sep; 70(3):416-26. PubMed ID: 26391636
[TBL] [Abstract][Full Text] [Related]
17. High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma.
Franzius C; Bielack S; Sciuk J; Vollet B; Jürgens H; Schober O
Nuklearmedizin; 1999; 38(8):337-40. PubMed ID: 10615669
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study Comparing
Löfgren J; Mortensen J; Rasmussen SH; Madsen C; Loft A; Hansen AE; Oturai P; Jensen KE; Mørk ML; Reichkendler M; Højgaard L; Fischer BM
J Nucl Med; 2017 Nov; 58(11):1778-1785. PubMed ID: 28798033
[TBL] [Abstract][Full Text] [Related]
19. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
